The Greek parliament announced on Tuesday the results of a judicial investigation into alleged bribes paid to public officials by Basel-based NovartisExternal link over nearly a decade to boost subscriptions of their products at public hospitals.
“This is a massive scandal that has stunned Greek society,” government spokesman Dimitris Tzanakopoulos said.
Under Greek law, politicians do not face prosecution directly from judicial authorities. Allegations must first be referred to parliament for review before lawmakers vote to strip the accused of their automatic immunity.
The politicians named include current Bank of Greece governor Yannis Stournaras and EU Home Affairs Commissioner Dimitris Avramopoulos, plus former conservative prime minister Antonis Samaras, the caretaker prime minister Panagiotos Pikramenos in 2012 and five former health ministers. They have all denied the allegations.
Samaras, the former conservative prime minister who served between 2012 and 2015, said the allegations against him were politically motivated, and vowed to file a lawsuit against left-wing Prime Minister Alexis Tsipras.
“This is the most ruthless but also most ridiculous conspiracy ever,” he said.
Novartis said it is cooperating with Greek authorities.
Popular Stories
More
Foreign affairs
What Trump’s return or a new Harris administration would mean for Switzerland
Should raw milk sales be banned or should consumers decide?
Swiss food regulations do not allow raw milk to be sold for direct consumption. However, a loophole allows 400 raw milk vending machines to do just that.
COP29: Swiss NGOs call for strong financial support
This content was published on
Ahead of COP29, Swiss NGOs call for wealthy nations to pay $1,000 billion a year to help other countries solve climate problems.
Real Swiss wages likely to rise in 2025, says UBS bank
This content was published on
Higher wages and falling inflation are likely to boost Swiss purchasing power, which will be dragged back by rising health premiums.
This content was published on
Switzerland has a new tectonic map at a scale of 1:500,000, containing updates to geometry, distribution and nomenclature of the tectonic units.
This content was published on
Swiss artist Daniel Spoerri, known for his artworks using leftover food with dirty cutlery and crockery, has passed away in Vienna at the age of 94.
Climate change tipped to alter Swiss avalanche patterns by 2100
This content was published on
Climate change is expected to result in fewer avalanches overall in Switzerland but to increase the danger of wet snow avalanches by 2100.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
New Novartis chief eyes productivity revolution
This content was published on
Vas Narasimhan estimates that using digital technology more efficiently could save up to 25% on the cost of clinical trials.
Will exclusive collaborations yield more drug breakthroughs?
This content was published on
Recently FDA-approved, Novartis's pioneering immunotherapy was developed through an agreement with University of Pennsylvania researchers.
Pharma turns to big data to gauge care and pricing
This content was published on
Struggling to keep pace with digitisation, big pharma companies are turning to big data to drive future growth. Swiss-based Novartis is no different.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.